Barr Back In The Ring Over Plan B

Law360, New York (August 18, 2006, 12:00 AM EDT) -- Amid controversy surrounding Barr Pharmaceuticals Inc.’s move to make its morning after contraceptive pill available without a prescription, the drug maker has refiled its application with the U.S. Food and Drug Administration to sell Plan B over the counter to women over 18.

Barr—which makes Plan B through subsidiary Duramed Pharmaceuticals Inc.— submitted a revised application on Friday seeking federal approval to sell the Plan B "morning after" pill without a prescription, the FDA said.

Carol A. Cox, vice president of investor relations and corporate communications...
To view the full article, register now.



Case Information

Case Title

Tummino et al v. von Eschenbach

Case Number



New York Eastern

Nature of Suit

Other Statutory Actions


Edward R. Korman

Date Filed

January 21, 2005

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.